Regentis Biomaterials Receives CE Mark Approval for GelrinC Implant
Regentis Biomaterials received CE Mark approval for a GelrinC biodegradable implant based on denatured human fibrinogen for the treatment of articular knee cartilage defects. Aug 28, 2017